Stockreport

ActoBio Therapeutics™ Doses First Patient in Phase Ib/IIa Clinical Study of AG019 for the Treatment of Type 1 Diabetes

INTREXON CORP  (XON) 
Last intrexon corp earnings: 11/12 07:30 am Check Earnings Report
US:NYSE Investor Relations: investors.dna.com